INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 21S · 3 late76 trades$25.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05CFCheng Chi Fung0B / 42S42 trades$15.33M
  6. 06RARothblatt Martine A0B / 33S33 trades$5.50M
  7. 07RJRubinstein Julie0B / 32S32 trades$5.55M
  8. 08LBLeach Bryan0B / 30S30 trades$7.97M
  9. 09AOAtay Oguzhan0B / 30S30 trades$7.55M
  10. 10JDJenkins William D Jr0B / 30S30 trades$13.38M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K

Form 4 transactions

21,638 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
23
CV
Capital V LLC10% Owner
DSPViant Technology Inc.
Open-market sale · 10b5-1 plan
SELL$180K
15.0K sh
Mar 18, 2026Mar 19, 2026
Page 362 of 541
← PrevNext →
traded Mar 18, 2026
+1d
SEC Form 4

Evidence

23
GA
Geller AdamChief Product Officer
ZSZscaler, Inc.
Open-market sale · 10b5-1 plan
SELL$233K
1,485 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

23
CV
Capital V LLC10% Owner
DSPViant Technology Inc.
Open-market sale · 10b5-1 plan
SELL$100K
8,760 sh
Mar 19, 2026Mar 19, 2026
traded Mar 19, 2026
+0dSEC Form 4

Evidence

23
VC
Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner
DSPViant Technology Inc.
Open-market sale · 10b5-1 plan
SELL$60K
5,000 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

23
AN
Agrawal NitinChief Financial Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$25K
300 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

23
VT
Vanderhook TimothyDirector, CEO and Chairman, 10% Owner
DSPViant Technology Inc.
Open-market sale · 10b5-1 plan
SELL$60K
5,000 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

22
GA
Geller AdamChief Product Officer
ZSZscaler, Inc.
Open-market sale · 10b5-1 plan
SELL$321K
2,094 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

22
WM
Woolsey Staci MChief Financial Officer
GVAGRANITE CONSTRUCTION INC
Open-market sale · 10b5-1 plan
SELL$183K
1,523 sh
Mar 19, 2026Mar 19, 2026
traded Mar 19, 2026
+0dSEC Form 4

Evidence

21
TS
Tamari ShaharDirector, COO
GLBEGlobal-E Online Ltd.
Open-market sale · 10b5-1 plan
SELL$563K
16.7K sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

21
LT
Larkin Kyle TDirector, President & CEO
GVAGRANITE CONSTRUCTION INC
Open-market sale · 10b5-1 plan
SELL$877K
7,314 sh
Mar 19, 2026Mar 19, 2026
traded Mar 19, 2026
+0dSEC Form 4

Evidence

20
VC
Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner
DSPViant Technology Inc.
Open-market sale · 10b5-1 plan
SELL$33K
2,920 sh
Mar 19, 2026Mar 19, 2026
traded Mar 19, 2026
+0dSEC Form 4

Evidence

20
BA
Beer James ADirector
ZSZscaler, Inc.
Open-market sale · 10b5-1 plan
SELL$27K
177 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

20
TB
Ticho BarryCHIEF MEDICAL OFFICER
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$191K
6,100 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

20
TB
Ticho BarryCHIEF MEDICAL OFFICER
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$86K
2,587 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

20
TB
Ticho BarryCHIEF MEDICAL OFFICER
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$117K
3,577 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

20
VT
Vanderhook TimothyDirector, CEO and Chairman, 10% Owner
DSPViant Technology Inc.
Open-market sale · 10b5-1 plan
SELL$33K
2,920 sh
Mar 19, 2026Mar 19, 2026
traded Mar 19, 2026
+0dSEC Form 4

Evidence

19
CV
Capital V LLC10% Owner
DSPViant Technology Inc.
Open-market sale · 10b5-1 plan
SELL$177K
15.0K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

19
VC
Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner
DSPViant Technology Inc.
Open-market sale · 10b5-1 plan
SELL$59K
5,000 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

19
VT
Vanderhook TimothyDirector, CEO and Chairman, 10% Owner
DSPViant Technology Inc.
Open-market sale · 10b5-1 plan
SELL$59K
5,000 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

18
KA
Kelly Patrick ArthurCo-President and COO
CIFRCipher Digital Inc.
Open-market sale · 10b5-1 plan
SELL$533K
35.6K sh
Mar 16, 2026Mar 19, 2026
traded Mar 16, 2026
+3dSEC Form 4

Evidence

16
BD
Baroni DarioPresident, IDL
MCDMCDONALDS CORP
Open-market sale · 10b5-1 plan
SELL$194K
600 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

15
VO
Verjus Nathalie Claude OdileCompany Secretary
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$15K
5,000 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

15
PJ
Peterson JustinChief Technology Officer
TWTradeweb Markets Inc.
Open-market sale · 10b5-1 plan
SELL$401K
3,212 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

13
TB
Ticho BarryCHIEF MEDICAL OFFICER
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$3,384
103 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

13
TB
Ticho BarryCHIEF MEDICAL OFFICER
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$15K
483 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

13
TB
Ticho BarryCHIEF MEDICAL OFFICER
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$44K
1,461 sh
Mar 19, 2026Mar 19, 2026
traded Mar 19, 2026
+0dSEC Form 4

Evidence

12
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$1.44M
11.1K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

12
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$1.10M
8,754 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

12
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$1.02M
7,907 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

12
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$1.81M
13.9K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

12
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$3.00M
22.8K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

12
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$5.75M
43.3K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

12
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$2.44M
18.1K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

12
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$2.98M
22.3K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

11
WC
Wiechmann Andrew C.Chief Financial Officer
MSCIMSCI Inc.
Open-market sale · 10b5-1 plan
SELL$252K
450 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

9
TR
Thurman Alex R.SVP & CHIEF FINANCIAL OFFICER
GKOSGLAUKOS Corp
Open-market sale · 10b5-1 plan
SELL$62K
625 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

9
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$462K
3,624 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

9
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$728K
5,746 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

9
WT
Weingarten TomerDirector, President, CEO
SSentinelOne, Inc.
Open-market sale · 10b5-1 plan
SELL$562K
38.9K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

8
CR
Chatwani RobertPresident General Mgr, Growth
DOCUDOCUSIGN, INC.
Open-market sale · 10b5-1 plan
SELL$189K
3,824 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence